Clinical Trial Update: Letrozole Dose Increments in PCOS Patients Resistant to Letrozole [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating increasing doses of letrozole in PCOS patients who are resistant to standard letrozole; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: Beni-Suef University | Conditions: Polycystic Ovary Syndrome | Phase 3 | Status: COMPLETED